Praxis Precision Medicines (PRAX) Net Cash Flow Growth (5y) (2024 - 2026)

Praxis Precision Medicines (PRAX) Net Cash Flow Growth (5y) (2024 - 2026) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Oculis Holding AG	68,725.60 Bn	68,725.31 Bn	-
2	Nanobiotix	1,953.19 Bn	1,953.13 Bn	-
3	Akari Therapeutics	1,132.35 Bn	1,132.35 Bn	-
4	BeOne Medicines	472.73 Bn	467.94 Bn	1.35 Bn
5	Vertex Pharmaceuticals	123.52 Bn	116.27 Bn	2.59 Bn
6	Regeneron Pharmaceuticals	69.74 Bn	60.99 Bn	3.31 Bn
7	Belite Bio	63.09 Bn	63.09 Bn	-
8	Argenx Se	56.42 Bn	51.24 Bn	1.41 Bn
9	Revolution Medicines	37.76 Bn	37.76 Bn	-
10	Praxis Precision Medicines	9.29 Bn	8.50 Bn	-

Download Data